Wang G - Search Results

1

ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.

Wang G, Zhan Y, Wang H, Li W. Wang G, et al. Among authors: wang h. Cancer Chemother Pharmacol. 2012 Mar;69(3):799-805. doi: 10.1007/s00280-011-1763-0. Epub 2011 Oct 29. Cancer Chemother Pharmacol. 2012. PMID: 22037880

2

Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer.

Chen S, Wang G, Niu X, Zhao J, Tan W, Wang H, Zhao L, Ge Y. Chen S, et al. Among authors: wang h, wang g. Cancer Lett. 2014 Jun 28;348(1-2):20-8. doi: 10.1016/j.canlet.2014.02.010. Epub 2014 Feb 15. Cancer Lett. 2014. PMID: 24534203

3

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.

Niu X, Zhao J, Ma J, Xie C, Edwards H, Wang G, Caldwell JT, Xiang S, Zhang X, Chu R, Wang ZJ, Lin H, Taub JW, Ge Y. Niu X, et al. Among authors: wang g, wang zj. Clin Cancer Res. 2016 Sep 1;22(17):4440-51. doi: 10.1158/1078-0432.CCR-15-3057. Epub 2016 Apr 21. Clin Cancer Res. 2016. PMID: 27103402 Free PMC article.

4

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.

Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, Taub JW, Lin H, Ge Y. Zhao J, et al. Among authors: wang g, wang y. Oncotarget. 2016 Jun 7;7(23):34785-99. doi: 10.18632/oncotarget.9185. Oncotarget. 2016. PMID: 27166183 Free PMC article.

5

Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.

Su Y, Li X, Ma J, Zhao J, Liu S, Wang G, Edwards H, Taub JW, Lin H, Ge Y. Su Y, et al. Among authors: wang g. Biochem Pharmacol. 2018 Feb;148:13-26. doi: 10.1016/j.bcp.2017.11.022. Epub 2017 Dec 5. Biochem Pharmacol. 2018. PMID: 29208365 Free PMC article.

6

Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.

Liu F, Knight T, Su Y, Edwards H, Wang G, Wang Y, Taub JW, Lin H, Sun L, Ge Y. Liu F, et al. Among authors: wang g, wang y. Target Oncol. 2019 Jun;14(3):351-364. doi: 10.1007/s11523-019-00638-4. Target Oncol. 2019. PMID: 31115744

7

Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer.

Liu S, Zhao S, Dong Y, Wang T, Niu X, Zhao L, Wang G. Liu S, et al. Among authors: wang g, wang t. Cancer Chemother Pharmacol. 2021 Mar;87(3):415-423. doi: 10.1007/s00280-020-04210-0. Epub 2021 Jan 3. Cancer Chemother Pharmacol. 2021. PMID: 33392641

8

Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines.

Guo Y, Xu X, Qi W, Xie C, Wang G, Zhang A, Ge Y. Guo Y, et al. Among authors: wang g. Mol Med Rep. 2012 Mar;5(3):734-8. doi: 10.3892/mmr.2011.738. Epub 2011 Dec 23. Mol Med Rep. 2012. PMID: 22200913

9

Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells.

Wang G, Edwards H, Caldwell JT, Buck SA, Qing WY, Taub JW, Ge Y, Wang Z. Wang G, et al. Among authors: wang z. PLoS One. 2013 Sep 30;8(9):e76662. doi: 10.1371/journal.pone.0076662. eCollection 2013. PLoS One. 2013. PMID: 24098799 Free PMC article.

10

Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.

Wang G, Chen S, Edwards H, Cui X, Cui L, Ge Y. Wang G, et al. Oncol Rep. 2014 Dec;32(6):2789-94. doi: 10.3892/or.2014.3525. Epub 2014 Oct 3. Oncol Rep. 2014. PMID: 25333301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,363 results

Search Page

Filters